---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-265867"
form_type: "8-K"
ticker: "LBRX"
cik: "0001691082"
company_name: "LB PHARMACEUTICALS INC"
filed_at: "2026-06-10T20:16:40+00:00"
generated_at: "2026-06-10T20:26:48.495687+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# LB Pharmaceuticals CMO Anna Eramo resigns; will advise through September 15, 2026

## Summary
- Anna Eramo, M.D., resigns as CMO effective June 15, 2026; transitions to advisor role through Sept 15, 2026.
- Separation agreement includes base salary until June 15, 2027, prorated 2026 bonus, and accelerated vesting of 66,143 options.
- Company states departure is unrelated to clinical operations and expects no material impact on clinical milestones.
- Search for replacement underway; existing clinical teams will continue to oversee ongoing trials.

## SEC filing metadata
- accession: 0001193125-26-265867
- form_type: 8-K
- ticker: LBRX
- cik: 0001691082
- company_name: LB PHARMACEUTICALS INC
- filed_at: 2026-06-10T20:16:40+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1691082/000119312526265867/0001193125-26-265867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1691082/000119312526265867/d221514d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-265867
- JSON: https://secwatch.observer/filing/0001193125-26-265867.json
- Plain text: https://secwatch.observer/filing/0001193125-26-265867.txt

## Key facts
- Executive change
  Anna Eramo resigned as Chief Medical Officer at LB PHARMACEUTICALS INC.
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On June 8, 2026, she resigned from her position as Chief Medical Officer of the Company effective June 15, 2026 (the " Separation Date ").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1691082/000119312526265867/0001193125-26-265867-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.